Humatica advises the Riverside Company on their recent investment in Alter Pharma

ndetails

Humatica Ltd. was retained to advise the Riverside Company on its investment in Alter Pharma, a Belgian pharmaceutical group. Alter Pharma distributes EU-sourced pharmaceutical products to wholesalers pharmacies and hospitals. It also develops and reformulates generic pharmaceuticals using GMP approved third-party manufacturers, and sells them internationally through partnerships

Humatica provided organisational due diligence services for this transaction.

To view press release: Humatica Advisor to Riverside for AlterPharma

Related News

Humatica recognized for Best Organizational Due Diligence Solution 2024
20 Feb, 2024 By Humatica

Humatica recognized for Best Organizational Due Diligence Solution 2024

Humatica was recognized for having the Best Organizational Due Diligence Solution by Private Equity Wire in their 2024 European Awards. The award was based on…

Read more arrowicon
Humatica recognized as Best Specialist Private Equity Consulting Firm 2023
23 Nov, 2023 By Humatica

Humatica recognized as Best Specialist Private Equity Consulting Firm 2023

Wealth & Finance International Magazine has announced the winners of this year’s Management Consulting Awards. For the second year running, the Management Consulting Awards looks…

Read more arrowicon
Humatica advises Freshstream on its investment in Project Better Energy
09 Nov, 2023 By Humatica

Humatica advises Freshstream on its investment in Project Better Energy

Humatica advises Freshstream on their investment on Project Better Energy, one of the leading players in the domestic renewable energy sector in the UK  Humatica, the…

Read more arrowicon